UAB Comprehensive Diabetes Center members are conducting cutting-edge research into the causes and mechanisms of diabetes, working on novel disease-altering therapies, training future generations of diabetes researchers and clinicians and providing the highest quality innovative care to diabetes patients.
Ongoing projects in the UCDC span clinical, translational and basic research and encompass autoimmune type 1 diabetes, type 2 diabetes, diabetes complications, beta cell biology, oxidative stress, signaling and metabolism as well as diabetes risk factors, epidemiology, community outreach, intervention studies and drug discovery. UCDC faculty research projects are supported by funding from the National Institutes of Health, Juvenile Diabetes Research Foundation, American Diabetes Association, American Heart Association, Veterans Affairs and the Centers for Disease Control.
COVID-19 Statement
Diabetes is one of the major underlying conditions that puts people at greater risk for severe illness associated with COVID-19. The UCDC is therefore continuing to work hard to keep individuals with diabetes healthy and push forward on critical diabetes research, while maintaining all necessary safety precautions for its members and the community.